Ikapharmindo Putramas Tbk. vs Niramas Utama Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp196 (market cap 333.56B, 96.7K 24h volume), while Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume). The key difference: Niramas Utama Tbk. is far larger — about 2.5× Ikapharmindo Putramas Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 96.7K). Which is the better fit depends on your goals.
| IKPM | JELI | |
|---|---|---|
Market Cap | 333.56B | 848.22B |
Volume | 96.7K | 10.75M |
Lot | 967 | 107.48K |
Turnover | 19.03M | 6.9B |
Average Price | 196.81 | 642.24 |
Value | 19.03M | 6.9B |
Indicative Equilibrium Price | — | 635 |
Indicative Equilibrium Volume | — | 6.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →